the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

WHO member states extend pandemic agreement negotiations for another year

GENEVA: Member states of the World Health Organisation (WHO) agreed on Saturday to extend the talks over the pandemic agreement for another year, allowing for more time needed to finalise the landmark treaty to combat future pandemics and enhance preparedness, reported Xinhua.

The Intergovernmental Negotiating Body (INB), which was established in December 2021 to draft the agreement and guide the negotiation process, will continue its mandate to deliver the agreement by the next World Health Assembly in 2025, or earlier, if possible, at a special session of the health assembly in 2024.

“There was a clear consensus amongst all Member States on the need for a further instrument to help the world better fight a full-blown pandemic,“ said INB co-chair Precious Matsoso.

This year’s World Health Assembly also agreed on a package of amendments to another international instrument, the International Health Regulations (2005) (IHR), introducing a definition of a pandemic emergency to trigger more effective international collaboration in response to a potential pandemic.

The amendments will bolster countries’ ability to detect and respond to future outbreaks and pandemics by strengthening their national capacities, and coordination between member states, on disease surveillance, information sharing, and response, said WHO Director-General Tedros Adhanom Ghebreyesus.

“Today’s strengthening of the IHR provides powerful momentum to complete the Pandemic Agreement, which, once finalised, can help to prevent a repeat of the devastation to health, societies, and economies caused by COVID-19,“ the WHO head added. – Bernama, Xinhua

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings